OraSure Technologies/ US68554V1089 /

9/22/2023 9:59:59 PM	Chg. +0.04	Volume	Bid-	Ask-	High	Low
5.65USD	+0.71%	19,663 Turnover: 110,855.74	-Bid Size: -	-Ask Size: -	5.68	5.58

GlobeNewswire 3/29/2022 HOUSING WORKS & FOUNDING CHAIR JAMES HUNIFORD ANNOUNCE LINEUP OF TOP INTERIOR DESIGNERS FOR ANNUAL D...

GlobeNewswire 3/22/2022 OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensi...

GlobeNewswire 2/23/2022 OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up

GlobeNewswire 2/16/2022 OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022...

GlobeNewswire 1/31/2022 InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launch...

GlobeNewswire 1/25/2022 OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe

GlobeNewswire 1/13/2022 InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants

Newsfile Corp 1/10/2022 Annovis Bio Enhances Leadership Team with Two Senior Appointments

GlobeNewswire 1/5/2022 OraSure Technologies Announces Actions to Enhance Stockholder Value

GlobeNewswire 12/14/2021 OraSure Technologies Announces 2022 Annual Meeting Date

GlobeNewswire 11/30/2021 OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery ...

GlobeNewswire 11/19/2021 OraSure Technologies to Present at Upcoming Investor Conferences

GlobeNewswire 11/9/2021 OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gal...

GlobeNewswire 11/8/2021 OraSure Technologies Appoints Two New Members to the Board of Directors

GlobeNewswire 11/3/2021 OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contra...

GlobeNewswire 11/2/2021 U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptom...

GlobeNewswire 10/27/2021 OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p...

GlobeNewswire 10/4/2021 OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of Intel...

GlobeNewswire 9/27/2021 TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer

GlobeNewswire 9/23/2021 OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Su...

GlobeNewswire 9/20/2021 OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency...

GlobeNewswire 9/2/2021 OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan

GlobeNewswire 8/3/2021 OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

GlobeNewswire 7/27/2021 OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2...

GlobeNewswire 6/17/2021 OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference